The Benign Multi-Disciplinary Meeting (MDM) - a New Way to Manage Benign Breast Disease
Association of Breast Surgery ePoster Library. Lewis R. 05/15/17; 166214; P118
Ms. Rebecca Lewis
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)
Introduction:
This study aims to assess the benefits of separating benign cases (P3, U3, M3) from the main breast cancer MDT.
Methods:
Each week, a separate benign MDT is held before the main breast MDT. Patients from all four hospitals in the Trust are included. There is multi-disciplinary attendance – a consultant surgeon, a consultant radiologist, a breast cancer clinical nurse practitioner and the MDT co-ordinator. All suspected benign disease cases are assessed.
The outcomes are 1. Discharge
2. Further tests
3. A clinic appointment
This is communicated to the patient via a phone call from the clinical nurse practitioner, followed by a letter to the patient and the patient's GP.
Results:
This approach has improved the care of benign patients and led to a reduction in the number of clinic appointments for benign disease (approximately 2,100 patients discussed in the 18 months since this started, with the saving of around 1,500 appointments).
General improvements due to this system –
1. Compliance with commissioners regarding a reduction in clinic appointments
2. NHS commissioning money is saved
3. Rapid results to the patient (one week)
4. Rapid resolution if further diagnostics or intervention required
5. The opportunity for general advice by the nurse practitioner during the phone call
6. Increased time available in both main MDT and clinic to discuss complicated and malignant cases
Conclusions
This is a model of care that could be rolled out to other trusts and improve overall efficiency and patient care.
This study aims to assess the benefits of separating benign cases (P3, U3, M3) from the main breast cancer MDT.
Methods:
Each week, a separate benign MDT is held before the main breast MDT. Patients from all four hospitals in the Trust are included. There is multi-disciplinary attendance – a consultant surgeon, a consultant radiologist, a breast cancer clinical nurse practitioner and the MDT co-ordinator. All suspected benign disease cases are assessed.
The outcomes are 1. Discharge
2. Further tests
3. A clinic appointment
This is communicated to the patient via a phone call from the clinical nurse practitioner, followed by a letter to the patient and the patient's GP.
Results:
This approach has improved the care of benign patients and led to a reduction in the number of clinic appointments for benign disease (approximately 2,100 patients discussed in the 18 months since this started, with the saving of around 1,500 appointments).
General improvements due to this system –
1. Compliance with commissioners regarding a reduction in clinic appointments
2. NHS commissioning money is saved
3. Rapid results to the patient (one week)
4. Rapid resolution if further diagnostics or intervention required
5. The opportunity for general advice by the nurse practitioner during the phone call
6. Increased time available in both main MDT and clinic to discuss complicated and malignant cases
Conclusions
This is a model of care that could be rolled out to other trusts and improve overall efficiency and patient care.
Introduction:
This study aims to assess the benefits of separating benign cases (P3, U3, M3) from the main breast cancer MDT.
Methods:
Each week, a separate benign MDT is held before the main breast MDT. Patients from all four hospitals in the Trust are included. There is multi-disciplinary attendance – a consultant surgeon, a consultant radiologist, a breast cancer clinical nurse practitioner and the MDT co-ordinator. All suspected benign disease cases are assessed.
The outcomes are 1. Discharge
2. Further tests
3. A clinic appointment
This is communicated to the patient via a phone call from the clinical nurse practitioner, followed by a letter to the patient and the patient's GP.
Results:
This approach has improved the care of benign patients and led to a reduction in the number of clinic appointments for benign disease (approximately 2,100 patients discussed in the 18 months since this started, with the saving of around 1,500 appointments).
General improvements due to this system –
1. Compliance with commissioners regarding a reduction in clinic appointments
2. NHS commissioning money is saved
3. Rapid results to the patient (one week)
4. Rapid resolution if further diagnostics or intervention required
5. The opportunity for general advice by the nurse practitioner during the phone call
6. Increased time available in both main MDT and clinic to discuss complicated and malignant cases
Conclusions
This is a model of care that could be rolled out to other trusts and improve overall efficiency and patient care.
This study aims to assess the benefits of separating benign cases (P3, U3, M3) from the main breast cancer MDT.
Methods:
Each week, a separate benign MDT is held before the main breast MDT. Patients from all four hospitals in the Trust are included. There is multi-disciplinary attendance – a consultant surgeon, a consultant radiologist, a breast cancer clinical nurse practitioner and the MDT co-ordinator. All suspected benign disease cases are assessed.
The outcomes are 1. Discharge
2. Further tests
3. A clinic appointment
This is communicated to the patient via a phone call from the clinical nurse practitioner, followed by a letter to the patient and the patient's GP.
Results:
This approach has improved the care of benign patients and led to a reduction in the number of clinic appointments for benign disease (approximately 2,100 patients discussed in the 18 months since this started, with the saving of around 1,500 appointments).
General improvements due to this system –
1. Compliance with commissioners regarding a reduction in clinic appointments
2. NHS commissioning money is saved
3. Rapid results to the patient (one week)
4. Rapid resolution if further diagnostics or intervention required
5. The opportunity for general advice by the nurse practitioner during the phone call
6. Increased time available in both main MDT and clinic to discuss complicated and malignant cases
Conclusions
This is a model of care that could be rolled out to other trusts and improve overall efficiency and patient care.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}